Drawing for CARE ACCESS

USPTO serial 97113870

CARE ACCESS

Reviewed by CopyMark Law Group

Reg. 7210023Status 700Registered
Filing date
Status date
Registration date
Nov 7, 2023
Examiner
BELL, MARLENE D
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CARE ACCESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RACHELLE A. DUBOW

RACHELLE A. DUBOW MORGAN, LEWIS & BOCKIUS LLPONE FEDERAL STREETBOSTON, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Recruitment advertisement services, namely, contacting physicians for the purpose of recruiting patients for participation in clinical trials for the testing of drugs by means of direct methods of marketing, namely, e-mail marketing, SMS messaging, electronic medical record (EMR) messaging, in-clinic communications, in-clinic promotional material, and telephone calls, and indirect methods of marketing communications, namely, social media, search engine marketing, inquiry marketing, internet marketing, mobile marketing, blogging and other forms of passive, sharable or viral communications channels of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approvalACTIVE—
042Conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 7, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 7, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 22, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 22, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 20, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 30, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 30, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 30, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 30, 2023EXPIEX PARTE APPEAL-INSTITUTED—
Jun 30, 2023JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jun 30, 2023EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Apr 2, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 2, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 2, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 28, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 27, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2022DOCKASSIGNED TO EXAMINER—
Nov 16, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 11, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance